The gyrA subgenes of a quinolone-resistant Enterobacter cloacae clinical isolate (ofloxacin MIC, 16mg/L) and of a control, E. cloacae NCTC 10005 (ofloxacin MIC, 0.03 mg/L), were amplified by polymerase chain reaction (PCR) and sequenced. The resistant isolate had mutations at the codons for amino acids 83, 89 and 90. The first of these mutations led to replacement of serine-83 by tyrosine, whereas the other mutations were silent. Digestion of PCR-amplified DNA fragments with the restriction enzyme HinfI detected mutations at the same site in gyrA in six further quinolone resistant E. cloacae isolates.
Introduction
An increase in the incidence of serious diseases caused by Enterobacter cloacae has been observed recently [ 1, 2] . Nosocomial infections caused by E. cloacae are often treated with fluoroquinolones, because of resistance to many other agents [3] . Quinolones act primarily by inhibiting DNA gyrase (topoisomerase 11) [4-61, which is essential for bacterial growth [7] . DNA gyrase transiently breaks the DNA strands and introduces negative superhelical turns in an ATPdependent process [8] . Apart from being involved in DNA replication, this enzyme regulates the initiation of transcription of several genes. The enzyme is a tetramer with two A and two B subunits encoded by the genes gyrA and gyrB, respectively.
Mechanisms of resistance to fluoroquinolones have been studied in several gram-negative organisms including Escherichia coli, Pseudornonas aeruginosa, Acinetobacter baurnannii and Salmonella typhirnuriurn [9- 121 and were found to be chromosomally determined. In most cases, high-level fluoroquinolone resistance in these organisms maps to mutations in gyrA [13, 141 . Such mutations result in a simultaneous increase in resistance towards all quinolones. Most mutations in Esch. coli lie in the 5' end of gyrA, between nucleotides 199 (corresponding to Ala-67 in the protein product) and 318 (Gln-106). This region the tetracycline resistance gene in addition to the cloned wild-type gyrA gene of Esch. coli were used. Each of these plasmids was transferred into 10 randomly chosen isolates, with ofloxacin MICs 3 1 mg/L. To achieve transfer, the isolates were cultured in 10 ml volumes of Mueller Luria Broth [7] , whilst the donor strains were cultured overnight in 10-ml amounts of Mueller Luria broth containing tetracycline (WyethLederle, Vienna, Austria) 5 mg/L. Equal volumes (1 ml of donor and recipient were then mixed and the mixtures were centrihged (13 200 9) for 5 min at 4°C.
The pellets were suspended in 50-pl amounts of 0.15 M NaC1, spread on Mueller Luria agar and incubated for 5 h at 37°C to allow mating, then harvested into 3-ml volumes of sterile 0.15 M NaCl. Dilutions containing c. lo2 and lo4 ch/ml were made in 10-ml volumes of sterile water, and 100-pl volumes were spread on MacConkey agar (Oxoid, Basingstoke, Hants) containing tetracycline at 0, 20, 100 and 200 mg/L. Presumptive transconjugates recovered on this medium after incubation overnight at 37°C were subcultured on MacConkey agar plates containing tetracycline 100mg/L. They were then confirmed as E. cloacae and MICs were determined as above, but with tetracycline (5 mg/L) added to the Mueller Hinton broth to conserve the plasmids.
Polymerase chain reaction (PCR)
Two oligonucleotide primers (Dr Muller, Oligo-Ocom, Vienna Biocenter, Austria), Pri 1 (5'-TACACCGGT-CAACATTGAGG-3') and Pri2 (5'-TTAATGATTG-CCGCCGTCGG-3') were designed, on the basis of the known gyrA sequences of Esch. coli K-12. Pril was identical in sequence to nucleotide positions 24-43, and Pri2 was complementary to positions 652-671. These were used to amplify gyrA by PCR [17] . Template DNA was prepared from each strain by heat (37°C) and cold shock (-196°C) treatment of single colonies suspended in water, followed by centrifugation. The template DNA was taken from the resulting supernate and amplification was performed in a final volume of 50 pl containing 5 pl of DNA template (30-50 ng), 0.8 pl of each primer (Pril and Pri2 each at 20 p~) , 5 pl of deoxynucleoside triphosphates (dATP, dCTP, dGTP and dTTP; 2 mM each; Perkin-Elmer, Branchburg, NJ, USA), and 5 pl of Taq buffer containing 1 .O-2.0 U of Taq polymerase (PerkinElmer), which was added after the sample had been heated. Thirty amplification cycles were used, with the following temperature profiles: 92°C for 35 s; 64°C for 1 min and 74°C for 2 min.
Sequence analysis
PCR fragments were subjected to phenol-chloroform extraction and then precipitated with ethanol [ 181. Double-stranded PCR fragments were sequenced by an automated DNA sequencing system, with a fluorescence sequencer (LI-COR; Lincoln, Nebraska, USA) ~9 1 .
Restriction fragment length polymorphism (RFLP) of PCR-ampl$ed DNA
The 648-bp fragment amplified by PCR was digested with HinfI [17] (Amersham, Bucks) at 37°C for 1 h. The cleavage products were profiled by electrophoresis in gels containing agarose 1.5% in TAE buffer and ethidium bromide staining [ 171.
Results

Antimicrobial susceptibility
The susceptibilities of clinical E. cloacae isolates are shown in Table 1 
Dominance test
The susceptibilities of donor strains, E. cloacae isolates and transconjugants are shown in Table 1 . All transconjugants with plasmids pLA29 17 and pNJR3-2 became resistant to tetracycline. Four isolates (nos, 5, 15, 32 and 105) of those acquiring plasmid pNJR3-2 retained diminished susceptibility to ofloxacin, but six (isolate nos. 19, 67, 68, 89, 110 and 132) became more sensitive to this quinolone. Notably, the isolates in which acquisition of pNJR3-2 reduced or eliminated resistance were those that began with the highest levels of resistance to the quinolones. In contrast to its gyrA coding derivative, pLA29 17 had no effect on quinolone MICs.
PCR products and point mutations in gyrA
PCR products consistently had the mobility expected for a 648-bp DNA fragment (Fig. 1) . Sequencing of the 338-bp fragment corresponding to the N-terminal region of GyrA from the most quinolone-resistant isolate (no. 89) showed three alterations in comparison with that of the quinolone-susceptible control E. cloacae NCTC 10005 (Table 2) . Silent mutations were present in the codons determining amino acids 89 (ATC to ATT) and 90 (GTT to GTC); in addition, the codon corresponding to amino acid 83 was altered from TCC in the control to TAC in the resistant isolate, indicating a serine to tyrosine substitution.
PCR-RFLP
PCR products of QRDR region were 648 bp long and were expected to have two ' Hinfl recognition sites. Thus, HinfI digestion was predicted to yield three (Fig. 2, panel a) . However, mutation at the sequence corresponding to amino acid position 83 -as found in isolate 89 -removes one HinfI site, so that digestion generated only two fragments, with sizes of 320 and 328 bp (Fig.  2, panel b) . All the clinical isolates (19, 67, 68, 89, 110, 132) for which the MICs of ofloxacin were 3 1 mg/L, and that gave reversion of resistance in the dominance test, showed these two-band patterns after Hinf I digestion and electrophoresis.
Discussion
10005 were amplified by PCR, and sequenced [20] . Analysis showed that gyrA from the resistant isolate had a mutation leading to replacement of serine 83 by tyrosine, together with silent mutations in the codons determining amino acids 89 and 90. Mutation at serine 83 has also been reported as the first mutation step in quinolone resistance in Esch. coli [2] . Hinf I digestion of PCR-amplified DNA implied mutation at serine 83 in the gyrA genes of six further isolates with ofloxacin MICs 2 1 mg/L. PCR-RFLP was a useful method to detect gyrA mutants at amino position 83, serine, and, in contrast to the dominance tests, was simple and rapid [21] . This method could provide a rapid primary characterization of highly fluoroquinolone-resistant isolates.
Quinolone resistance is often associated with point Quinolone resistance can be associated with reduced mutations in gyrA. This can be tested by a compleimpermeability of the outer membrane, active efflux, mentation method in which plasmids encoding quinoand mutations in gyrB [14, 21, 23, 24] . Four strains in lone-sensitive GyrA are transferred into resistant this study retained diminished susceptibility after isolates. Sensitive gyrA is dominant to resistant so, if conjugation, implying the presence of one of these the original resistance is caused by mutation to gyrA, it mechanisms, rather than gyrA mutation. is lost [7] . This method detects all mutations to gyrA, but gives no data On their nature' To address this aspect, DrA genes from the most quinolone-resistant
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